BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36562118)

  • 21. Surgical management of pancreatic neuroendocrine tumors: an introduction.
    Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
    [No Abstract]   [Full Text] [Related]  

  • 22. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
    Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
    J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Dillhoff M; Maithel SK; Pawlik TM
    HPB (Oxford); 2020 Feb; 22(2):215-223. PubMed ID: 31235429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
    Gudmundsdottir H; Pery R; Graham RP; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Habermann EB; Nagorney DM; Cleary SP
    Ann Surg Oncol; 2022 Oct; 29(11):6949-6957. PubMed ID: 35731358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study.
    Alfieri S; Butturini G; Boggi U; Pietrabissa A; Morelli L; Vistoli F; Damoli I; Peri A; Fiorillo C; Pugliese L; Ramera M; De Lio N; Di Franco G; Esposito A; Landoni L; Rosa F; Menghi R; Doglietto GB; Quero G;
    Langenbecks Arch Surg; 2019 Jun; 404(4):459-468. PubMed ID: 31055639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
    Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
    ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.
    Barenboim A; Lahat G; Nachmany I; Nakache R; Goykhman Y; Geva R; Osher E; Scapa E; Wolf I; Orbach L; Brazowski E; Isakov O; Klausner JM; Lubezky N
    J Gastrointest Surg; 2020 Jun; 24(6):1366-1374. PubMed ID: 31197692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
    Fernández-Cruz L; Blanco L; Cosa R; Rendón H
    World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients.
    Bilimoria KY; Tomlinson JS; Merkow RP; Stewart AK; Ko CY; Talamonti MS; Bentrem DJ
    J Gastrointest Surg; 2007 Nov; 11(11):1460-7; discussion 1467-9. PubMed ID: 17846854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
    Primavesi F; Klieser E; Cardini B; Marsoner K; Fröschl U; Thalhammer S; Fischer I; Hauer A; Urbas R; Kiesslich T; Neureiter D; Zitt M; Klug R; Wundsam H; Sellner F; Karner J; Függer R; Cakar-Beck F; Kornprat P; Öfner D; Stättner S;
    Eur J Surg Oncol; 2019 Feb; 45(2):198-206. PubMed ID: 30262324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
    Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
    Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
    Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
    Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of resection of the primary pancreatic neuroendocrine tumor in the multidisciplinary treatment of patients with unresectable synchronous liver metastases: a case series.
    Kondo NI; Ikeda Y; Maehara S; Sugimoto R; Nishiyama K; Sakaguchi Y
    JOP; 2013 Jul; 14(4):415-22. PubMed ID: 23846939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine Tumours.
    Reher D; Fehrenbach U; Kayser A; Pape UF; Henes FO; Cremer B; Hörsch D; Izbicki J; Lohse AW; Rinke A; Schrader J
    Neuroendocrinology; 2022; 112(6):595-605. PubMed ID: 34515157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What Is the Role of Lymph Node Resections in Small Islet Tumors?
    Gangi A; Ferrone CR
    Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic resection of pancreatic neuroendocrine tumors.
    Al-Kurd A; Chapchay K; Grozinsky-Glasberg S; Mazeh H
    World J Gastroenterol; 2014 May; 20(17):4908-16. PubMed ID: 24803802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivisceral resection of nonfunctional pancreatic neuroendocrine neoplasm with nearby organ invasion: a case report.
    Zhang C; Niu W; Xu Y; Lu Y; Huang L; Li S; Jiang X; Wu J
    Front Endocrinol (Lausanne); 2023; 14():1236685. PubMed ID: 37822595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.